Changlin Zou

441 total citations
28 papers, 364 citations indexed

About

Changlin Zou is a scholar working on Oncology, Surgery and Epidemiology. According to data from OpenAlex, Changlin Zou has authored 28 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 8 papers in Surgery and 7 papers in Epidemiology. Recurrent topics in Changlin Zou's work include Colorectal Cancer Surgical Treatments (5 papers), Colorectal and Anal Carcinomas (4 papers) and Lung Cancer Research Studies (4 papers). Changlin Zou is often cited by papers focused on Colorectal Cancer Surgical Treatments (5 papers), Colorectal and Anal Carcinomas (4 papers) and Lung Cancer Research Studies (4 papers). Changlin Zou collaborates with scholars based in China. Changlin Zou's co-authors include Xuebang Zhang, Hanbin Chen, Congying Xie, Meng Su, Lucheng Zhu, Wenzheng Xia, Meng Hou, Wen-Hua Luo, Juan Wei and Fang Wu and has published in prestigious journals such as PLoS ONE, Cell Death and Disease and European Journal of Nuclear Medicine and Molecular Imaging.

In The Last Decade

Changlin Zou

26 papers receiving 360 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Changlin Zou China 10 133 108 66 62 51 28 364
Huanhuan Liu China 13 106 0.8× 130 1.2× 62 0.9× 181 2.9× 64 1.3× 28 436
Ahmed O. Elmehrath Egypt 8 117 0.9× 100 0.9× 91 1.4× 29 0.5× 33 0.6× 14 372
Masanobu Enomoto Japan 12 204 1.5× 127 1.2× 93 1.4× 36 0.6× 126 2.5× 62 485
Lifan Wang China 11 73 0.5× 147 1.4× 34 0.5× 65 1.0× 29 0.6× 34 347
Eunyoung Ko South Korea 12 152 1.1× 142 1.3× 57 0.9× 40 0.6× 85 1.7× 25 476
Ali Dastranj Tabrizi Iran 10 61 0.5× 121 1.1× 54 0.8× 20 0.3× 65 1.3× 32 434
Jin Kyung An South Korea 8 53 0.4× 95 0.9× 58 0.9× 22 0.4× 36 0.7× 28 274
Yiliang Bi China 10 118 0.9× 63 0.6× 105 1.6× 24 0.4× 93 1.8× 15 301
Se-Kyung Lee South Korea 8 138 1.0× 148 1.4× 82 1.2× 50 0.8× 22 0.4× 16 376
Alan I. Valderrama-Treviño Mexico 4 161 1.2× 101 0.9× 87 1.3× 28 0.5× 99 1.9× 28 387

Countries citing papers authored by Changlin Zou

Since Specialization
Citations

This map shows the geographic impact of Changlin Zou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changlin Zou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changlin Zou more than expected).

Fields of papers citing papers by Changlin Zou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changlin Zou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changlin Zou. The network helps show where Changlin Zou may publish in the future.

Co-authorship network of co-authors of Changlin Zou

This figure shows the co-authorship network connecting the top 25 collaborators of Changlin Zou. A scholar is included among the top collaborators of Changlin Zou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changlin Zou. Changlin Zou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Deng, Xia, Kejie Li, Xuemei Zhang, et al.. (2025). The clinical value of FAPI PET/CT in delineating target volumes for nasopharyngeal carcinoma. European Journal of Nuclear Medicine and Molecular Imaging. 53(1). 105–115.
3.
Ren, Xiaolin, Huijuan He, Dahai Zhang, et al.. (2023). Curcumol β-cyclodextrin inclusion complex enhances radiosensitivity of esophageal cancer under hypoxic and normoxic condition. Japanese Journal of Radiology. 41(11). 1275–1289. 7 indexed citations
4.
5.
Zhu, Lucheng, Changlin Zou, Jianfang Wang, et al.. (2021). Thoracic radiotherapy and concurrent almonertinib for unresectable stage III EGFR-mutated non-small-cell lung cancer: a phase 2 study. BMC Cancer. 21(1). 511–511. 8 indexed citations
6.
Xia, Wenzheng, Changlin Zou, Hanbin Chen, Congying Xie, & Meng Hou. (2020). Immune checkpoint inhibitor induces cardiac injury through polarizing macrophages via modulating microRNA-34a/Kruppel-like factor 4 signaling. Cell Death and Disease. 11(7). 575–575. 70 indexed citations
8.
Chen, Xingxing, Huifang Li, Meng Su, et al.. (2016). Knowledge, Attitudes, and Practices Related to Preoperative Chemoradiotherapy in Rectal Cancer Patients. Gastroenterology Research and Practice. 2016. 1–6.
9.
Chen, Xingxing, Huifang Li, Meng Su, et al.. (2016). Weekly Versus Triweekly Cisplatin-Based Chemotherapy Concurrent With Radiotherapy in the Treatment of Cervical Cancer. International Journal of Gynecological Cancer. 27(2). 344–349. 25 indexed citations
10.
Zhang, Wenyi, Huifang Li, Meng Su, et al.. (2016). A Simple Scoring System Predicting the Survival Time of Patients with Bone Metastases after RT. PLoS ONE. 11(7). e0159506–e0159506. 11 indexed citations
11.
Su, Meng, et al.. (2015). 18F-fluorodeoxyglucose positron emission tomography for predicting tumor response to radiochemotherapy in nasopharyngeal carcinoma. Strahlentherapie und Onkologie. 191(8). 642–648. 4 indexed citations
12.
Zhang, Xuebang, et al.. (2015). Activity guided isolation and modification of juglone from Juglans regia as potent cytotoxic agent against lung cancer cell lines. BMC Complementary and Alternative Medicine. 15(1). 396–396. 51 indexed citations
14.
Su, Meng, et al.. (2014). Primary anorectal malignant melanoma treated with neoadjuvant chemoradiotherapy and sphincter-sparing surgery: A case report. Oncology Letters. 7(5). 1605–1607. 5 indexed citations
15.
Zhu, Lucheng, Wen-Hua Luo, Meng Su, et al.. (2013). A Model to Discriminate Malignant from Benign Thyroid Nodules Using Artificial Neural Network. PLoS ONE. 8(12). e82211–e82211. 39 indexed citations
16.
Zhu, Lucheng, Wen-Hua Luo, Meng Su, et al.. (2013). Comparison between artificial neural network and Cox regression model in predicting the survival rate of gastric cancer patients. Biomedical Reports. 1(5). 757–760. 43 indexed citations
18.
Xu, Fang, Juan Wei, Xianghui Li, et al.. (2012). Synthesis and antineoplastic activity of novel water-soluble curcumol derivatives. Chemistry of Natural Compounds. 48(1). 54–55. 1 indexed citations
19.
Zou, Changlin, et al.. (2003). [Etiologic fraction and interaction of risk factors for primary hepatocellular carcinoma in Wenzhou, Zhejiang Province].. PubMed. 37(5). 355–7. 3 indexed citations
20.
Qiu, Sufang, et al.. (2000). CT via percutaneous splenoportography: experiment and application.. PubMed. 113(3). 257–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026